Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
